These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 32859709)
21. Prognostic value of [ Takenaka J; Watanabe S; Abe T; Hirata K; Uchiyama Y; Kimura R; Shinohara N; Kudo K Ann Nucl Med; 2023 Jan; 37(1):10-17. PubMed ID: 36301465 [TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of 18F-LMI1195 for in vivo imaging of pheochromocytoma in the MENX tumor model. Gaertner FC; Wiedemann T; Yousefi BH; Lee M; Repokis I; Higuchi T; Nekolla SG; Yu M; Robinson S; Schwaiger M; Pellegata NS J Nucl Med; 2013 Dec; 54(12):2111-7. PubMed ID: 24136933 [TBL] [Abstract][Full Text] [Related]
23. Adrenal tracer uptake by Noordzij W; Glaudemans AWJM; Schaafsma M; van der Horst-Schrivers ANA; Slart RHJA; van Beek AP; Kerstens MN Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1560-1566. PubMed ID: 31011769 [TBL] [Abstract][Full Text] [Related]
24. Imaging of pheochromocytoma and paraganglioma. Brink I; Hoegerle S; Klisch J; Bley TA Fam Cancer; 2005; 4(1):61-8. PubMed ID: 15883712 [TBL] [Abstract][Full Text] [Related]
25. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
26. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma. Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961 [TBL] [Abstract][Full Text] [Related]
27. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665 [TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma. Nakamoto R; Nakamoto Y; Ishimori T; Togashi K Clin Nucl Med; 2016 Nov; 41(11):e465-e472. PubMed ID: 27607159 [TBL] [Abstract][Full Text] [Related]
31. The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma. Kong G; Schenberg T; Yates CJ; Trainer A; Sachithanandan N; Iravani A; Ravi Kumar A; Hofman MS; Akhurst T; Michael M; Hicks RJ J Clin Endocrinol Metab; 2019 Nov; 104(11):5091-5099. PubMed ID: 30977831 [TBL] [Abstract][Full Text] [Related]
32. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T; Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Reynolds JC; Ling A; Eisenhofer G; Lazúrová I; Adams KT; Whatley MA; Widimsky J; Pacak K Endocr Relat Cancer; 2008 Mar; 15(1):311-23. PubMed ID: 18310297 [TBL] [Abstract][Full Text] [Related]
33. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695 [TBL] [Abstract][Full Text] [Related]
34. Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery. Nockel P; El Lakis M; Gaitanidis A; Merkel R; Patel D; Nilubol N; Prodanov T; Pacak K; Kebebew E Ann Surg; 2019 Apr; 269(4):741-747. PubMed ID: 29334561 [TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas. Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma. Sharma P; Dhull VS; Arora S; Gupta P; Kumar R; Durgapal P; Malhotra A; Chumber S; Ammini AC; Kumar R; Bal C Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):494-504. PubMed ID: 24158184 [TBL] [Abstract][Full Text] [Related]
38. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464 [TBL] [Abstract][Full Text] [Related]
39. Performance of Han S; Suh CH; Woo S; Kim YJ; Lee JJ J Nucl Med; 2019 Mar; 60(3):369-376. PubMed ID: 30030341 [TBL] [Abstract][Full Text] [Related]
40. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Timmers HJ; Kozupa A; Chen CC; Carrasquillo JA; Ling A; Eisenhofer G; Adams KT; Solis D; Lenders JW; Pacak K J Clin Oncol; 2007 Jun; 25(16):2262-9. PubMed ID: 17538171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]